What is the R‑on‑T phenomenon on an electrocardiogram?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

R-on-T Phenomenon on ECG

The R-on-T phenomenon occurs when a premature ventricular complex (PVC) falls on the T wave of the preceding beat, coinciding with the vulnerable period of ventricular repolarization when regional dispersion of refractoriness creates conditions for potential reentry and life-threatening arrhythmias. 1, 2

Electrocardiographic Definition

  • The R-on-T phenomenon is the superimposition of an ectopic ventricular beat on the T wave of a preceding beat 3
  • This timing is critical because the T wave represents transmural dispersion of repolarization, when some ventricular regions have recovered excitability while others remain refractory 2
  • The vulnerable period corresponds to the T wave on the surface ECG, creating conditions where unidirectional block and reentry can be initiated 1

Mechanisms of Arrhythmia Initiation

Two distinct mechanisms exist for R-on-T arrhythmogenesis:

  • "R-to-T" mechanism: A PVC arising focally from one region propagates into another region with delayed recovery, resulting in unidirectional conduction block and reentry initiation 1
  • "R-from-T" mechanism: The PVC is causally generated from the repolarization gradient itself (the T wave), rather than being a separate event—the trigger arises directly from the underlying tissue instabilities that create the vulnerable substrate 1
  • The R-on-T phenomenon may result from transmural propagation of phase 2 reentry or phase 2 early afterdepolarization, potentially initiating polymorphic ventricular tachycardia or fibrillation 2

Clinical Significance and Risk Assessment

The actual arrhythmic risk of R-on-T is substantially lower than historically believed:

  • R-on-T VPCs are rare events, representing only 1.8% of total VPCs in acute myocardial infarction patients 4
  • R-on-T is not a critical determinant of primary ventricular fibrillation in acute myocardial infarction and represents few of the initiating beats of paroxysmal ventricular tachycardia 3
  • When the capacity for sustained repetitive beating has not been clinically evident, R-on-T is unlikely to result in ventricular tachyarrhythmias, even in coronary heart disease 3
  • R-on-T VTs occur more frequently during thrombolysis than after (0.8 vs 0.05 VPCs/hour), and when they occur, they are significantly faster than non-R-on-T VTs (374 ± 56 ms vs 411 ± 69 ms) 4

High-Risk Clinical Contexts

R-on-T carries meaningful risk in specific settings:

  • Acute myocardial infarction: The inability to always identify precursors of tachyarrhythmias strengthens the argument for prophylactic treatment 3
  • Pacemaker malfunction: Asynchronous ventricular pacing or loss of sensing in synchronous pacemakers can cause R-on-T phenomenon leading to polymorphic ventricular tachycardia and cardiac arrest 5
  • Brugada syndrome and early repolarization syndrome: These conditions involve prominent transmural voltage gradients during repolarization that increase vulnerability to R-on-T triggered arrhythmias 2

Common Pitfalls

  • Do not assume all R-on-T events will trigger sustained arrhythmias—the vast majority do not result in dangerous rhythms 3, 4
  • Recognize that R-on-T represents at worst only a small risk in terms of sudden death outside the acute myocardial infarction setting 3
  • In pacemaker patients, verify proper sensing function to prevent iatrogenic R-on-T phenomenon from pacing stimuli 5
  • Consider both trigger suppression and substrate modification when designing antiarrhythmic strategies, as R-from-T mechanisms require addressing underlying dynamic tissue instabilities simultaneously 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.